Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting.
J Clin Microbiol
; 49(7): 2711-3, 2011 Jul.
Article
em En
| MEDLINE
| ID: mdl-21562100
ABSTRACT
In 271 Enterobacter blood culture isolates from 12 hospitals, extended-spectrum beta-lactamase (ESBL) prevalence varied between 0% and 30% per hospital. High prevalence was associated with dissemination, indicating the potential relevance of infection control measures. Screening with cefepime or Vitek 2, followed by a cefepime/cefepime-clavulanate Etest, was an accurate strategy for ESBL detection in Enterobacter isolates (positive predictive value, 100%; negative predictive value, 99%).
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Beta-Lactamases
/
Técnicas de Laboratório Clínico
/
Beta-Lactamas
/
Enterobacter
/
Antibacterianos
Tipo de estudo:
Diagnostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article